Quantcast
Last updated on April 16, 2014 at 8:06 EDT

Latest Bevacizumab Stories

New Brain Cancer Vaccine Displays Success In Second Clinical Trial
2012-04-18 06:44:44

Connie K. Ho for RedOrbit.com On Tuesday, April 17, researchers from the University of California, San Francisco (UCSF) presented results at the American Association of Neurological Surgeons (AANS) meeting in Miami, Florida that a new brain cancer vaccine tailored to individual subjects had been successful in its second clinical trial. The vaccine is for patients who suffer from recurrent glioblastoma multiforme, a type of cancer, and it has helped extend patients´ lives. The trial...

2012-04-17 14:48:56

Adding the drug bevacizumab (Avastin) to the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) — an approach approved by the FDA in 2006 — did not lead to significantly increase survival rates for patients over the age of 65 enrolled in Medicare, a new study by Dana-Farber Cancer Institute researchers has found. The study is being published in the April 18 Journal of the American Medical Association, a these issue on comparative effectiveness research....

2012-04-11 02:24:43

PLANO, Texas, April 11, 2012 /PRNewswire/ -- MacuCLEAR, Inc., a clinical stage specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, announced today it is beginning Phase III studies for its lead compound, MC-1101, for early-stage (Dry) age-related macular degeneration (AMD), based on positive feedback during the company's end-of-Phase II meeting with the FDA. MC-1101 is a proprietary, topically administered...

2012-04-10 09:10:30

A randomized controlled trial involving patients with persistent clinically significant diabetic macular edema (swelling of the retina) suggests the greater efficacy of bevacizumab compared with macular laser therapy that was previously demonstrated at 12 months was maintained through 24 months, according to a report published Online First by Archives of Ophthalmology, a JAMA Network publication. Modified Early Treatment Diabetic Retinopathy Study (ETDRS) macular laser therapy (MLT) has...

More Fake Cancer Drugs Make Their Way To America
2012-04-04 11:27:07

Another batch of counterfeit Avastin, a cancer fighting drug, has been discovered in the United States. The new batch of counterfeit drugs discovered in the US was purchased in Turkey and shipped through Britain, officials said on Wednesday. Though the business in between Turkey and the US is different this time around, this shipping pattern closely resembles an earlier episode. The fake version of the Roche Genentech drug was first discovered in February and was received by as many as 19...

2012-04-03 09:04:18

A combination of nab-paclitaxel and carboplatin for the treatment of non-small cell lung cancer may be a promising option for patients ineligible for treatment with bevacizumab, according to data presented at the AACR Annual Meeting 2012, held here March 31 - April 4. "The combination of carboplatin and nab-paclitaxel demonstrates promising efficacy with tolerable toxicity in patients with non-small cell lung cancer (NSCLC) ineligible for therapy with bevacizumab," said Gregory A....

2012-03-08 15:02:00

INCLINE VILLAGE, Nev., March 8, 2012 /PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced royalty revenue guidance for the first quarter ending March 31, 2012, of approximately $77 million, as compared with actual royalty revenue of $73 million for the first quarter of 2011, a five percent increase. Total revenue for the first quarter of 2012 is expected to be $6 million less than total revenue for the first quarter of 2011. The decline in expected total revenue is largely...

2012-03-08 10:40:00

LEUVEN, Belgium, March 8, 2012 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on developing innovative ophthalmic medicines, today issued a business update and its financial results for the full year ending December 31, 2011. Over the past 12 months, ThromboGenics has built its capabilities in anticipation of the launch of its lead product, ocriplasmin. It has filed a regulatory submission in Europe for ocriplasmin for...

2012-03-07 10:55:44

In a small study that included 25 patients with hereditary hemorrhagic telangiectasia (a genetic disorder that leads to abnormalities of blood vessels) and severe liver involvement with this disease, patients who received the drug bevacizumab had improved cardiac output and a reduction in the duration and number of episodes of nose bleeds, a potentially life-threatening complication for patients with this disorder, according to a study in the March 7 issue of JAMA. Hereditary hemorrhagic...

Counterfeit Cancer Drug Circulating Throughout The US
2012-02-15 13:28:34

Roche Genentech is warning doctors and patients that counterfeit vials of its cancer drug Avastin have been distributed in the U.S. The fake drugs do not contain the key ingredient in Avastin, which is used to help treat cancers of the colon, lung, kidney and brain. A spokeswoman for Roche Genentech said the counterfeit drug has been distributed to health care facilities in the U.S., but it´s unclear how many vials are in circulation in the U.S. The company said it is working...